Pulmonx (LUNG) Capital Expenditures (2019 - 2025)
Pulmonx (LUNG) posted quarterly Capital Expenditures of $80000.0 for Q3 2025, down 80.77% year-over-year from $416000.0 in Q3 2024, and up 900.0% quarter-over-quarter from -$10000.0 in Q2 2025.
Pulmonx (LUNG) Capital Expenditures (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Capital Expenditures for 7 consecutive years, with $80000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Capital Expenditures fell 80.77% year-over-year to $80000.0; the TTM figure through Sep 2025 stood at $550000.0 (down 64.19% YoY), while the FY2024 annual figure was $1.4 million, up 79.31% from the prior year.
- Capital Expenditures rose to $80000.0 in Q3 2025 per LUNG's latest filing, from -$10000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.6 million in Q3 2021 and bottomed at -$19000.0 in Q2 2023.
- Historically, Capital Expenditures has averaged $404315.8 across 5 years, with a median of $299000.0 in 2022.
- Annual changes were most pronounced in 2023 — Capital Expenditures tumbled 106.35% — and 2024, when it soared 2568.42%.
- Pulmonx's Capital Expenditures stood at $1.1 million in 2021, then tumbled by 84.67% to $176000.0 in 2022, then advanced by 13.64% to $200000.0 in 2023, then tumbled by 44.5% to $111000.0 in 2024, then retreated by 27.93% to $80000.0 in 2025.
- Business Quant data shows LUNG's Capital Expenditures at $80000.0 in Q3 2025, -$10000.0 in Q2 2025, and $369000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Pulmonx | 94.56 Mn | 24.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 80,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Jun 30, 2025 | -10,000.00 |
| Jun 30, 2025 | -10,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Dec 31, 2024 | 111,000.00 |
| Dec 31, 2024 | 111,000.00 |
| Sep 30, 2024 | 416,000.00 |
| Sep 30, 2024 | 416,000.00 |
| Jun 30, 2024 | 469,000.00 |
| Jun 30, 2024 | 469,000.00 |
| Mar 31, 2024 | 451,000.00 |
| Mar 31, 2024 | 451,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 157,000.00 |
| Sep 30, 2023 | 157,000.00 |
| Jun 30, 2023 | -19,000.00 |
| Jun 30, 2023 | -19,000.00 |